Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Genome-Wide Association Studies Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The genome-wide association studies market has experienced substantial expansion in recent years. Its valuation is anticipated to rise from $2.27 billion in 2025 to $2.58 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.7%. This expansion during the historical period is primarily due to the broadening of genetic research initiatives, the increased availability of genomic datasets, an uptick in academic population studies, the rising adoption of genotyping technologies, and advancements in data analysis capabilities.
The genome-wide association studies market size is anticipated to undergo significant expansion over the forthcoming years. It is projected to reach $4.26 billion by 2030, driven by a compound annual growth rate (CAGR) of 13.4%. The impetus for this growth in the forecast period can be linked to the escalating demand for precision medicine insights, increasing investments in genomic analytics platforms, the broadening scope of AI-driven genetic research, an expanding pharmaceutical interest in target discovery, and a greater emphasis on predictive healthcare models. Prominent trends within this period include the increased embrace of large-scale population genomics studies, the rising adoption of advanced bioinformatics platforms, the deeper integration of GWAS in drug discovery, the expansion of personalized medicine research programs, and an enhanced focus on disease risk prediction.
Get A Free Sample Report With In-Depth Market Insights:
Genome-Wide Association Studies Market Industry Drivers: What’s Behind The Revenue Growth?
The increasing demand for personalized medicine is projected to drive the expansion of the genome-wide association studies market. Personalized medicine represents a healthcare strategy that customizes treatment and prevention plans to align with an individual’s specific genetic profile, lifestyle, and environmental factors. The growing adoption of this approach stems primarily from innovations in genomics, which facilitate the accurate identification of genetic variations and the development of bespoke treatments. Genome-wide association studies (GWAS) are crucial for personalized medicine, as they pinpoint genetic variations associated with diseases, thereby enabling the creation of targeted treatment strategies. These studies contribute to better healthcare outcomes by offering insights into individual risk profiles and supporting precision therapies. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, noted that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a considerable increase from the 12 approved in 2022. Consequently, the rising demand for personalized medicine is a key factor propelling the growth of the genome-wide association studies market.
Genome-Wide Association Studies Market Segment Analysis: What Are The Core Market Categories?
The genome-wide association studies market covered in this report is segmented –
1) By Product Type: Genotyping Services, Genotyping Kits And Reagents, Software And Data Analysis Tools, Other Product Types
2) By Application: Drug Discovery, Disease Risk Assessment, Personalized Medicine, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals And Clinics, Other End-Users
Subsegments:
1) By Genotyping Services: Whole Genome Sequencing (Wgs), Exome Sequencing, Targeted Genotyping
2) By Genotyping Kits And Reagents: Dna Extraction Kits, Sequencing Reagents, Library Preparation Kits
3) By Software And Data Analysis Tools: Bioinformatics Platforms, Data Visualization Tools, Statistical Analysis Software
4) By Other Product Types: Sample Collection Devices, Quality Control Tools, Laboratory Consumables
Genome-Wide Association Studies Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the genome-wide association studies market are focused on developing innovative solutions, such as advanced research platforms, to accelerate disease discovery and personalized medicine applications. An advanced research platform is an integrated system of tools and technologies that enables large-scale genomic data generation, analysis, and interpretation specifically for genome-wide association studies. For example, in January 2025, 23andMe Holding Co., a US-based biotechnology company, launched Discover23, a consumer-focused platform designed for genetic insights and ancestry exploration. It allows biopharma collaborators to access comprehensive genetic data within a trusted environment powered by Lifebit. The platform offers analysis-ready genome-wide association studies (GWAS) on over 1,000 disease cohorts, which are derived from billions of phenotypic data points collected from millions of consenting participants. The goal of this advanced research platform is to speed up drug discovery by aiding researchers in identifying novel disease biology and potential drug targets, thereby improving clinical trial success, all while ensuring participant privacy.
Genome-Wide Association Studies Market Top Companies Driving Competitive Growth
Major companies operating in the genome-wide association studies market are F. Hoffmann-La Roche AG, AstraZeneca plc, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Regeneron Pharmaceuticals Inc., Eurofins Scientific SE, Laboratory Corporation of America Holdings, Daiichi Sankyo Company Limited, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Databricks Inc., Broad Institute of MIT and Harvard, BGI Genomics Co. Ltd., deCODE genetics Inc., Genomics England Ltd., CD Genomics Inc., Veritas Genetics Inc., Finngen, The Wellcome Sanger Institute
View The Full Genome-Wide Association Studies Market Report:
Genome-Wide Association Studies Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the genome-wide association studies market in 2025. The regions covered in the genome-wide association studies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model







